A randomized, double-blind, placebo-controlled trial of pleconaril for the treatment of neonates with enterovirus sepsis

Journal of the Pediatric Infectious Diseases Society

Volumn 5, Issue 1, 2015, Pages 53-62

  Abzug, Mark J ^a   Michaels, Marian G ^b   Wald, Ellen ^c   Jacobs, Richard F ^d   Romero, José R ^d,e   Sánchez, Pablo J ^f,q   Wilson, Gregory ^g   Krogstad, Paul ^h   Storch, Gregory A ⁱ   Lawrence, Robert ^j   Shelton, Mark ^k   Palmer, April ^l   Robinson, Joan ^m   Dennehy, Penelope ⁿ   Sood, Sunil K ^o   Cloud, Gretchen ^p   Jester, Penelope ^p   Acosta, Edward P ^p   Whitley, Richard ^p   Kimberlin, David ^p  

^a University of Colorado Denver and Children s Hospital Colorado   (United States)

^b CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^c UNIVERSITY OF WISCONSIN MILWAUKEE   (United States)

^d UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^e UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^f UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^g VANDERBILT UNIVERSITY   (United States)

^h UNIVERSITY OF CALIFORNIA   (United States)

ⁱ WASHINGTON UNIVERSITY   (United States)

^j UNIVERSITY OF FLORIDA   (United States)

^k Cooks Children Hospital ^*  (United States)

^l UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

^m UNIVERSITY OF ALBERTA   (Canada)

ⁿ HASBRO CHILDREN'S HOSPITAL   (United States)

^o Northwell Health   (United States)

^p UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^q NATIONWIDE CHILDREN S HOSPITAL   (United States)

more..

Author keywords

Enterovirus; Hepatitis; Neonatal; Pleconaril; Sepsi

Indexed keywords

PLACEBO; PLECONARIL; ANTIVIRUS AGENT; OXADIAZOLE DERIVATIVE;

ARTICLE; CHILD; CLINICAL ASSESSMENT; CLINICAL EVALUATION; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; ENTEROVIRUS INFECTION; FEMALE; HEPATITIS; HUMAN; IC90; INFANT; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PRIORITY JOURNAL; QUANTITATIVE ASSAY; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; SEPSIS; SURVIVAL RATE; UNSPECIFIED SIDE EFFECT; VIROLOGY; VIRUS CULTURE; BLOOD; CLINICAL TRIAL; COMPLICATION; DRUG EFFECTS; ENTEROVIRUS; ENTEROVIRUS INFECTIONS; GENETICS; ISOLATION AND PURIFICATION; MULTICENTER STUDY; NEONATAL SEPSIS; NEWBORN; OROPHARYNX; RECTUM; URINE;

ANTIVIRAL AGENTS; DOUBLE-BLIND METHOD; ENTEROVIRUS; ENTEROVIRUS INFECTIONS; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; NEONATAL SEPSIS; OROPHARYNX; OXADIAZOLES; RECTUM;

EID: 85006201183     PISSN: 20487193     EISSN: 20487207     Source Type: Journal    
DOI: 10.1093/jpids/piv015     Document Type: Article

References (20)

1. Abzug MJ. Presentation, diagnosis, and management of enterovirus infection in neonates. Paediatr Drugs 2004; 6:1-10.
2. Abzug MJ. The enteroviruses: problems in need of treatments. J Infect 2014; 68:S108-14.
3. Abzug MJ. Prognosis for neonates with enterovirus hepatitis and coagulopathy. Pediatr Infect Dis J 2001; 20:758-63.
4. Freund MW, Kleinveld G, Krediet TG, van Loon AM, Verboon-Maciolek MA. Prognosis for neonates with enterovirus myocarditis. Arch Dis Child Fetal Neonatal Ed 2010; 95:F206-12.
5. Tebruegge M, Curtis N. Enterovirus infections in neonates. Semin Fetal Neonatal Med 2009; 14:222-7.
6. Abzug MJ, Keyserling HL, Lee ML, Levin MJ, Rotbart HA. Neonatal enterovirus infection: virology, serology, and effects of intravenous immune globulin. Clin Infect Dis 1995; 20:1201-6.
7. Abzug MJ, Cloud G, Bradley J, et al. Double blind placebocontrolled trial of pleconaril in infants with enterovirusmeningitis. Pediatr Infect Dis J 2003; 22:335-41.
8. Desmond RA, Accortt NA, Talley L, Villano SA, Soong SJ, Whitley RJ. Enteroviral meningitis: natural history and outcome of pleconaril therapy. Antimicrob Agents Chemother 2006; 50: 2409-14.
9. Hayden FG, HerringtonDT, Coats TL, et al. Efficacy and safety of oral pleconaril for treatment of colds due to picornaviruses in adults: results of 2 double-blind, randomized, placebo-controlled trials. Clin Infect Dis 2003; 36:1523-32.
10. Rotbart HA. Antiviral therapy for enteroviral infections. Pediatr Infect Dis J 1999; 18:632-3.
11. Rotbart HA, Webster AD. Treatment of potentially lifethreatening enterovirus infections with pleconaril. Clin Infect Dis 2001; 32:228-35.
12. Pevear DC, Hayden FG, Demenczuk TM, Barone LR, McKinlay MA, Collett MS. Relationship of pleconaril susceptibility and clinical outcomes in treatment of common colds caused by rhinoviruses. Antimicrob Agents Chemother 2005; 49:4492-9.
13. Sawyer MH. Enterovirus infections: diagnosis and treatment. Pediatr Infect Dis J 1999; 18:1033-40.
14. Aradottir E, Alonso EM, Shulman ST. Severe neonatal enteroviral hepatitis treated with pleconaril. Pediatr Infect Dis J 2001; 20: 457-9.
15. Kearns GL, Bradley JS, Jacobs RF, et al. Single dose pharmacokinetics of pleconaril in neonates. Pediatr Infect Dis J 2000; 19:833-9.
16. Yang CF, De L, Yang SJ, et al. Genotype-specific in vitro amplification of sequences of the wild type 3 polioviruses from Mexico and Guatemala. Virus Res 1992; 24:277-96.
17. Ma JD, Nafziger AN, Rhodes G, Liu S, Bertino JS. Duration of pleconaril effect on cytochrome P450 3A activity in healthy adults using the oral biomarker midazolam. Drug Metab Dispos 2006; 34:783-5.
18. D'Argenio D, Schumitzky A, Wang X. ADAPT 5 User's Guide: Pharmacokinetic/Pharmacodynamic Systems Analysis Software. Los Angeles: Biomedical Simulations Resource; 2009: 1-316.
19. Abzug MJ, LoeffelholzM, Rotbart HA. Diagnosis of neonatal enterovirus infection by polymerase chain reaction. J Pediatr 1995; 126:447-50.
20. Kearns GL, Abdel-Rahman SM, James LP, et al. Single-dose pharmacokinetics of a pleconaril (VP63843) oral solution in children and adolescents. Antimicrob Agents Chemother 1999; 43: 634-8.